1 Alpha,25-Dihydroxyvitamin D3 and 1 Alpha-hydroxyvitamin D3 Prolong Survival Time of Mice Inoculated with Myeloid Leukemia Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1983 Jan 1

PMID 6296868

Citations 41

Authors

Y Honma

M Hozumi

E Abe

K Konno

M Fukushima

S Hata

Y Nishii

H F DeLuca

T Suda

Affiliations

Soon will be listed here.

Abstract

Syngeneic SL mice inoculated with murine myeloid leukemia cells (M1) all died of leukemia within 30 days. Treatment three times a week with 12.5-50 pmol per mouse of either 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3], the active form of vitamin D3, or its synthetic analog, 1 alpha-hydroxyvitamin D3 [1 alpha(OH)D3], considerably prolonged the survival time of mice inoculated with M1 cells. 1 alpha(OH)D3 was more effective than 1 alpha,25(OH)2D3 in increasing the survival time of the mice. 1 alpha(OH)D3 also increased the survival time of nude mice inoculated with M1 cells. The 1 alpha(OH)[3H]D3 administered intraperitoneally to tumor-bearing mice was converted very rapidly to 1 alpha,25(OH)2-[3H]D3. The chronic administration of 25 pmol of 1 alpha(OH)D3 to tumor-bearing mice for 30 days caused no appreciable hypercalcemia. These results indicate clearly that 1 alpha,25(OH)2D3 is effective not only in inducing differentiation of M1 cells in vitro, as previously reported [Abe, E., Miyaura, C., Sakagami, H., Takeda, M., Konno, K., Yamazaki, T., Yoshiki, S. & Suda, T. (1981) Proc. Natl. Acad. Sci. USA 78, 4990-4994], but also in prolonging the survival time of mice inoculated with M1 cells.

Citing Articles

The One-Hundred-Year Anniversary of the Discovery of the Sunshine Vitamin D: Historical, Personal Experience and Evidence-Based Perspectives.

Holick M Nutrients. 2023; 15(3).

PMID: 36771300 PMC: 9919777. DOI: 10.3390/nu15030593.

Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters.

Omran M, Shouman S, Abdelfattah R, Moussa H, Thabet N, Hamza M Curr Ther Res Clin Exp. 2022; 97:100684.

PMID: 36188630 PMC: 9519432. DOI: 10.1016/j.curtheres.2022.100684.

Vitamin D-Mediated Anti-cancer Activity Involves Iron Homeostatic Balance Disruption and Oxidative Stress Induction in Breast Cancer.

Bajbouj K, Sahnoon L, Shafarin J, Al-Ali A, Muhammad J, Karim A Front Cell Dev Biol. 2021; 9:766978.

PMID: 34820382 PMC: 8606886. DOI: 10.3389/fcell.2021.766978.

Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D.

Flamann C, Peter K, Kreutz M, Bruns H Front Immunol. 2019; 10:2586.

PMID: 31749811 PMC: 6848223. DOI: 10.3389/fimmu.2019.02586.

Calcitriol and cancer therapy: A missed opportunity.

Trump D Bone Rep. 2018; 9:110-119.

PMID: 30591928 PMC: 6303233. DOI: 10.1016/j.bonr.2018.06.002.

References

Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y . 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J. 1982; 204(3):713-9. PMC: 1158411. DOI: 10.1042/bj2040713. View

Honma Y, Kasukabe T, Okabe J, Hozumi M . Glucocorticoid binding and mechanism of resistance in some clones of mouse myeloid leukemic cells resistant to induction of differentiation by dexamethasone. J Cell Physiol. 1977; 93(2):227-35. DOI: 10.1002/jcp.1040930208. View

Collins S, Ruscetti F, Gallagher R, Gallo R . Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A. 1978; 75(5):2458-62. PMC: 392573. DOI: 10.1073/pnas.75.5.2458. View

Honma Y, Takenaga K, Kasukabe T, Hozumi M . Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem Biophys Res Commun. 1980; 95(2):507-12. DOI: 10.1016/0006-291x(80)90813-x. View

Weiss B, Sachs L . Indirect induction of differentiation in myeloid leukemic cells by lipid A. Proc Natl Acad Sci U S A. 1978; 75(3):1374-8. PMC: 411474. DOI: 10.1073/pnas.75.3.1374. View

Benade L, Howard T, BURK D . Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4,-triazole. Oncology. 1969; 23(1):33-43. DOI: 10.1159/000224465. View

Fukushima M, Suzuki Y, Toira Y, Matsunaga I, Ochi K, Nagano H . Metabolism of 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in perfused rat liver. Biochem Biophys Res Commun. 1975; 66(2):632-8. DOI: 10.1016/0006-291x(75)90556-2. View

Miyaura C, Abe E, Kuribayashi T, Tanaka H, Konno K, Nishii Y . 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 1981; 102(3):937-43. DOI: 10.1016/0006-291x(81)91628-4. View

Huberman E, Callaham M . Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci U S A. 1979; 76(3):1293-7. PMC: 383237. DOI: 10.1073/pnas.76.3.1293. View

10.

Eisman J, Martin T, MacIntyre I, Frampton R, Moseley J, Whitehead R . 1,25-Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells). Biochem Biophys Res Commun. 1980; 93(1):9-15. DOI: 10.1016/s0006-291x(80)80238-5. View

11.

Manolagas S, Deftos L . Studies of the internalization of vitamin D3 metabolites by cultured osteogenic sarcoma cells and their application to a non-chromatographic cytoreceptor assay for 1,25-dihydroxyvitamin D3. Biochem Biophys Res Commun. 1980; 95(2):596-602. DOI: 10.1016/0006-291x(80)90826-8. View

12.

Kanis J, Russell R . Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives. Br Med J. 1977; 1(6053):78-81. PMC: 1604081. DOI: 10.1136/bmj.1.6053.78. View

13.

Colston K, Colston M, Feldman D . 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology. 1981; 108(3):1083-6. DOI: 10.1210/endo-108-3-1083. View

14.

Holick M, Tavela T, Holick S, Schnoes H, DeLuca F, Gallagher B . Synthesis of 1alpha-hydroxy [6-3H]vitamin D3 and its metabolism to 1alpha, 25-dihydroxy [6-3H]vitamin D3 in the rat. J Biol Chem. 1976; 251(4):1020-4. View

15.

Honma Y, Kasukabe T, Okabe J, Hozumi M . Glucorticoid-induced differentiation of cultured mouse myeloid leukemia cells. Gan. 1977; 68(2):241-6. View

16.

Lotem J, Sachs L . Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci U S A. 1979; 76(10):5158-62. PMC: 413099. DOI: 10.1073/pnas.76.10.5158. View

17.

Ichikawa Y . Differentiation of a cell line of myeloid leukemia. J Cell Physiol. 1969; 74(3):223-34. DOI: 10.1002/jcp.1040740303. View

18.

Brumbaugh P, Haussler M . 1 Alpha,25-dihydroxycholecalciferol receptors in intestine. II. Temperature-dependent transfer of the hormone to chromatin via a specific cytosol receptor. J Biol Chem. 1974; 249(4):1258-62. View

19.

DeLuca H, Schnoes H . Metabolism and mechanism of action of vitamin D. Annu Rev Biochem. 1976; 45:631-66. DOI: 10.1146/annurev.bi.45.070176.003215. View

20.

Ikekawa N, Koizumi N . Separation of vitamin D metabolites and their analogues by high-pressure liquid chromatography. J Chromatogr. 1976; 119:227-32. DOI: 10.1016/s0021-9673(00)86786-2. View